However, treating the animals with Carvacrol injected group (### P ≤ 0.001 vs. tumor and ***P ≤ 0.001 vs. normal) as well as oral and mixed groups (## P ≤ 0.01 vs. tumor and ***P ≤ 0.001 vs. normal) led to a notable elevated or improved TRAIL expression relative to the breast cancer group. This evidence concerns the gene TNFSF10 and breast carcinoma.